新疆伊犁地区驴脑组织亨德拉病毒感染情况调查

目的调查新疆伊犁地区草原放养驴群中亨德拉病毒(Hendra virus,HeV)中枢感染的流行情况。方法采用一步法实时荧光定量RT-PCR检测病毒核酸片段的方法对采自新疆伊犁地区草原放养、未接种HeV疫苗的65例驴脑组织进行HeV核蛋白(N)基因片段检测。结果65例驴脑组织成功进行一步法实时荧光定量RT-PCR检测,未检出阳性样本。结论目前尚未发现我国新疆伊犁地区放养驴中存在HeV中枢神经感染的证据,提示该地区出现HeV感染流行的可能性不大。     

新疆驴脑组织尼帕病毒N基因片段的检测

目的检测新疆伊犁草原地区放养新疆驴的脑组织样本中尼帕病毒(Nipah Virus,NiV)核蛋白(N)基因片段,调查该地区放养新疆驴NiV感染流行状况。方法采用一步法实时荧光定量逆转录聚合酶链反应(one-step Real-Time FQ RT-PCR)对采自新疆伊犁地区草原放养且未接种NiV疫苗的65例新疆驴脑组织进行NiVN基因片段检测。结果新疆驴脑组织标本中未检出NiV N基因片段。结论目前尚无证据表明我国新疆伊犁地区新疆驴中存在NiV感染,提示该地区短时间内爆发该病毒感染可能性较小。     

中国学术期刊网络出版总库节点文献新疆驴脑组织尼帕病毒N基因片段的检测

目的检测新疆伊犁草原地区放养新疆驴的脑组织样本中尼帕病毒（Nipah Virus,NiV）核蛋白（N）基因片段,调查该地区放养新疆驴NiV感染流行状况。方法采用一步法实时荧光定量逆转录聚合酶链反应（one-step Real-Time FQ RT-PCR）对采自新疆伊犁地区草原放养且未接种NiV疫苗的65例新疆驴脑组织进行NiVN基因片段检测。结果新疆驴脑组织标本中未检出NiV N基因片段。结论目前尚无证据表明我国新疆伊犁地区新疆驴中存在NiV感染,提示该地区短时间内爆发该病毒感染可能性较小。     

新疆伊犁地区马匹亨德拉病毒脑内感染情况调查

目的检测新疆伊犁地区天然牧场放养马群脑组织中亨德拉病毒（Hendra Virus,HeV）的核酸片段,调查该地区马群中枢神经系统HeV感染流行状况。方法针对HeV高度保守区核蛋白（N）基因设计特异性引物和探针,采用一步法实时荧光定量RT-PCR检测中枢神经系统感染样本中低浓度HeV RNA的方法,检测新疆伊犁草原地区天然放养且未接种HeV疫苗的183例马匹脑组织。结果最低特异性检出浓度可低至2.6×102copies/μL,与其他单股负链RNA病毒如同属的尼帕病毒（NiV）无交叉反应,对183例马脑组织进行一步法实时荧光定量RT-PCR检测,未检出阳性样本。结论初步流行病学研究尚未发现我国新疆伊犁地区天然牧场放养马匹中存在HeV感染的证据,提示该地区短时间内爆发亨德拉病毒感染的可能性小。     

蜱传脑炎病毒包膜糖蛋白胞外区的真核表达优化及其在血清学检测中的效果评价

目的:优化蜱传脑炎病毒包膜糖蛋白胞外区的密码子,提高其在真核系统中的表达量,为蜱传脑炎病毒感染血清的检测提供更为有效的检测抗原。方法:对蜱传脑炎病毒MDJ01株E蛋白胞外区进行真核密码子优化,获得优化的胞外区蛋白基因序列OPT-EC;将抗原基因与海肾萤光素酶基因Rluc融合构建重组质粒pc DNA3.1-Rluc-OPT-EC、pc DNA3.1-Rluc-EC,用重组质粒转染COS7细胞获得融合抗原Rluc-OPT-EC和Rluc-EC,并将融合抗原用于临床感染血清样本的免疫共沉淀检测以评价抗原的灵敏性和特异性。结果:真核密码子优化显著提高了Rluc-OPT-EC的表达量;OPT-EC的检测灵敏度可达86%以上,其对乙型脑炎病毒(JEV)感染血清、黄热病度(YFV)感染血清、禽流感病毒(AIV)感染血清和正常人血清的检测特异度高于90%,但是在西尼罗病毒(WNV)感染血清和登革病毒(DV)感染血清的检测中发生了交叉反应。结论:优化后的E蛋白胞外区蛋白作为TBEV感染的检测抗原,能够有效地区分JEV、YFV感染,但不能区分WNV和DV感染。     

马西尼罗热病毒E蛋白部分基因在大肠杆菌中的表达

参考GenBank发表的西尼罗病毒(west nile virus,WNV)的E蛋白基因序列,自行设计合成一对引物,利用RT-PCR扩增出了WMV E基因318bp片段,将其克隆入pMD18-T-Vector载体中,阳性克隆命名pMD-E,并进行序列分析。进一步亚克隆入表达载体pET-32a( )。重组质粒pET32a-E转化BL21(DE3)感受态细胞中表达,表达产物经SDS-PAGE可检测到分子量约为32kD的目的蛋白带,经薄层扫描分析,目的蛋白占菌体总蛋白的33．1%。表达产物纯化后,Wester-blotting分析证明表达产物能被WNV的阳性血清所识别,为下一步建立以表达产物为包被抗原建立检测马的WNV的ELISA方法打下了基础。     

西尼罗病毒感染对干扰素信号转导途径的影响

西尼罗病毒(West Nile virus, WNV)是蚊媒传播的嗜神经性黄病毒,也是全球病毒性脑炎最重要的病原体。宿主固有免疫在WNV感染所致疾病转归中扮演重要角色。WNV调控干扰素信号转导途径的关键分子以维持病毒复制。本文将综述WNV感染对干扰素信号转导途径调控的研究进展,包括RLR途径、TLR途径、Jak-STAT途径和其他相关途径。     

日本脑炎病毒E蛋白在酵母双杂交系统中的表达及其对报告基因激活作用的检测

用日本脑炎病毒(JEV)E蛋白基因片段构建酵母双杂交诱饵载体,并检测其表达产物对酵母细胞有无毒性作用及对报告基因有无激活作用。用RT—PCR从JEV感染的鼠脑中扩增出JEV E蛋白基因片段,克隆入pUCl9质粒,经测序正确后,再亚克隆入酵母双杂交诱饵载体pGBKT7中。将重组质粒导入酵母菌AHl09,检测其表达产物在酵母细胞中对报告基因有无激活作用。成功获得JEV E蛋白基因片段,表达的E蛋白对酵母菌AHl09无毒性,对报告基因亦无激活作用。为利用酵母双杂交GAL4系统3进行JEV细胞受体蛋白的研究奠定了基础。     

肠道病毒、乙脑病毒和腮腺炎病毒多重RT-PCR检测方法的建立

为建立针对肠道病毒(enterovirus,EV)、乙脑病毒(Japanese encephalitis virus,JEV)和腮腺炎病毒(mumps virus,MUV)的多重RT-PCR检测方法,分别选择肠道病毒的5′UTR基因、乙脑病毒的E基因和腮腺炎病毒M基因设计3对引物,建立同时检测肠道病毒、乙脑病毒和腮腺炎病毒的多重RT-PCR方法.以中国地区流行的与脑炎相关的麻疹病毒和风疹病毒cDNA为模板验证该检测方法的特异性,同时以梯度稀释的不同滴度的脊髓灰质炎病毒、乙脑病毒、腮腺炎病毒评估该检测方法的检出限.所建立的3种病毒的多重RT-PCR方法可同时或分别特异扩增肠道病毒、乙脑病毒和腮腺炎病毒的152 bp、429 bp和274 bp基因片段,基因序列分别与脊髓灰质炎病毒Sabin 1型5′UTR基因片段、乙型脑炎病毒SA-14-14-2株E基因片段及腮腺炎病毒S79基因片段序列一致;检出限分别达到78.1 CCID50/mL、312.5 PFU/mL、156.2 CCID50/mL;而对麻疹病毒和风疹病毒的扩增均为阴性.所建立的多重RT-PCR特异性和检出限良好,可用于上述3种脑炎病毒的快速检测.     

河北省儿童病毒性脑炎及脑膜炎埃可病毒30型VP1基因特征分析

为了解河北省儿童病毒性脑炎和脑膜炎患者中埃可病毒30型(Echovirus 30,E30)流行株基因特征及进化。本研究对2013～2015年间河北省儿童病毒性脑炎和脑膜炎病例中151份鉴定为肠道病毒阳性的脑脊液标本进行血清型鉴定,扩增E30流行株VP1区全基因序列;并与GenBank下载的325株E30的VP1基因序列进行同源性及亲缘关系分析。共获得18条E30 VP1基因序列。亲缘性分析显示E30可分为A～H 8个基因型;我国E30流行株主要为D、E、G和H基因型;本研究中E30流行株均为H基因型。18条E30 VP1基因核苷酸同源性为93.3%～100%,氨基酸同源性为98.2%～100%,与原型株(Bastianni)核苷酸和氨基酸同源性分别为80.9%～81.1%和91.4%～92.4%。该研究中18株E30与我国浙江省和山东省的分离株核苷酸和氨基酸同源性最高。2013～2015年间引起河北省儿童病毒性脑炎和脑膜炎的E30流行株为H基因型,可能存在多个传播链。     

Serologic survey of West Nile virus in horses from Central-West,Northeast and Southeast Brazil

Since the emergence of West Nile virus (WNV) in North America in 1999, there have been several reports of WNV activity in Central and South American countries. To detect WNV in Brazil, we performed a serological survey of horses from different regions of Brazil using recombinant peptides from domain III of WNV. Positive samples were validated with the neutralisation test. Our results showed that of 79 ELISA-positive horses, nine expressed WNV-specific neutralising antibodies. Eight of the infected horses were from the state of Mato Grosso do Sul and one was from the state of Paraíba. Our results provide additional evidence for the emergence of WNV in Brazil and for its circulation in multiple regions of the country.     

T Cell Epitope Mapping of the E-Protein of West Nile Virus in BALB/c Mice

West Nile virus (WNV) is a zoonotic virus, which is transmitted by mosquitoes. It is the causative agent of the disease syndrome called West Nile fever. In some human cases, a WNV infection can be associated with severe neurological symptoms. The immune response to WNV is multifactorial and includes both humoral and cellular immunity. T-cell epitope mapping of the WNV envelope (E) protein has been performed in C57BL/6 mice, but not in BALB/c mice. Therefore, we performed in BALB/c mice a T-cell epitope mapping using a series of peptides spanning the WNV envelope (E) protein. To this end, the WNV-E specific T cell repertoire was first expanded by vaccinating BALB/c mice with a DNA vaccine that generates subviral particles that resemble West Nile virus. Furthermore, the WNV structural protein was expressed in Escherichia coli as a series of overlapping 20-mer peptides fused to a carrier-protein. Cytokine-based ELISPOT assays using these purified peptides revealed positive WNV-specific T cell responses to peptides within the different domains of the E-protein.     

Antiviral peptides targeting the west nile virus envelope protein

West Nile virus (WNV) can cause fatal murine and human encephalitis. The viral envelope protein interacts with host cells. A murine brain cDNA phage display library was therefore probed with WNV envelope protein, resulting in the identification of several adherent peptides. Of these, peptide 1 prevented WNV infection in vitro with a 50% inhibition concentration of 67 muM and also inhibited infection of a related flavivirus, dengue virus. Peptide 9, a derivative of peptide 1, was a particularly potent inhibitor of WNV in vitro, with a 50% inhibition concentration of 2.6 muM. Moreover, mice challenged with WNV that had been incubated with peptide 9 had reduced viremia and fatality compared with control animals. Peptide 9 penetrated the murine blood-brain barrier and was found in the brain parenchyma, implying that it may have antiviral activity in the central nervous system. These short peptides serve as the basis for developing new therapeutics for West Nile encephalitis and, potentially, other flaviviruses.     

Spatial and Temporal Distribution of West Nile Virus in Horses in Israel (1997–2013) - from Endemic to Epidemics

With the rapid global spread of West Nile virus (WNV) and the endemic state it has acquired in new geographical areas, we hereby bring a thorough serological investigation of WNV in horses in a longstanding endemic region, such as Israel. This study evaluates the environmental and demographic risk factors for WNV infection in horses and suggests possible factors associated with the transition from endemic to epidemic state. West Nile virus seroprevalence in horses in Israel was determined throughout a period of more than a decade, before (1997) and after (2002 and 2013) the massive West Nile fever outbreak in humans and horses in 2000. An increase in seroprevalence was observed, from 39% (113/290) in 1997 to 66.1% (547/827) in 2002 and 85.5% (153/179) in 2013, with persistent significantly higher seroprevalence in horses situated along the Great Rift Valley (GRV) area, the major birds'' migration route in Israel. Demographic risk factors included age and breed of the horse. Significantly lower spring precipitation was observed during years with increased human incidence rate that occurred between 1997–2007. Hence, we suggest referring to Israel as two WNV distinct epidemiological regions; an endemic region along the birds'' migration route (GRV) and the rest of the country which perhaps suffers from cyclic epidemics. In addition, weather conditions, such as periods of spring drought, might be associated with the transition from endemic state to epidemic state of WNV.     

Mosquito‐borne West Nile virus (WNV) surveillance in the Upper Rhine Valley,Germany

West Nile virus (WNV) could be introduced into Germany via migratory birds originating from Africa or southern Europe and subsequently transmitted to indigenous birds, humans, or horses by mosquitoes. Neither the virus itself nor antibodies against WNV have yet to be found in mosquitoes and horses, whereas antibodies have been detected in migrating birds and in humans that were in close contact with birds. At present, the West Nile virus itself has yet to be detected in Germany. This investigation was conducted primarily in major bird breeding, resting, and roosting habitats (hotspots) in the Upper Rhine Valley. Adult mosquitoes were trapped using CO₂‐baited Encephalitis Vector Surveillance (EVS)‐traps and were tested for WNV by the VecTest WNV Antigen Assay. In 2007 and 2008, a total of 11,073 host‐seeking adult female mosquitoes (13 species) were tested, and all tests were negative for WNV. Statistical calculations could be performed only where sufficient numbers of mosquitoes were trapped. For these sites, WNV infection among mosquitoes could be ruled out with 80% certainty. For the evaluation of the WNV situation in Germany, the results of this investigation are a further indication that the virus has not yet arrived.     

Seroconversion for West Nile and St. Louis encephalitis viruses among sentinel horses in Colombia

We prospectively sampled flavivirus-na?ve horses in northern Colombia to detect West Nile virus (WNV) and St. Louis encephalitis virus (SLEV) seroconversion events, which would indicate the current circulation of these viruses. Overall, 331 (34.1%) of the 971 horses screened were positive for past infection with flaviviruses upon initial sampling in July 2006. During the 12-month study from July 2006-June 2007, 33 WNV seroconversions and 14 SLEV seroconversions were detected, most of which occurred in the department of Bolivar. The seroconversion rates of horses in Bolivar for the period of March-June 2007 reached 12.4% for WNV and 6.7% for SLEV. These results comprise the first serologic evidence of SLEV circulation in Colombia. None of the horses sampled developed symptoms of encephalitis within three years of initial sampling. Using seroconversions in sentinel horses, we demonstrated an active circulation of WNV and SLEV in northern Colombia, particularly in the department of Bolivar. The absence of WNV-attributed equine or human disease in Colombia and elsewhere in the Caribbean Basin remains a topic of debate and speculation.     

西尼罗病毒易感性研究现状

西尼罗病毒可引起鼠、人类及其他动物严重脑炎,近年来再度流行。基因研究分析表明近年来西尼罗病毒突变的速度逐渐加快,突变主要发生在基因编码区,这些突变可导致病毒蛋白E区、NS1区、NS2区及NS5区氨基酸序列的改变。西尼罗病毒感染主要发生于老龄及免疫缺陷动物或人群。西尼罗病毒的易感染性除与突变有重要关系外,与CCR5、OAS及CXCL10等受体及因子也有一定的关系。